Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population
Completed · Not applicable
Conditions studied: Barrett Esophagus
In brief
This will be a prospective randomized, controlled, virtual, patient study to measure the impact of EsoCheck/EsoGuard on health care provider's decision for upper endoscopy referral. The participants will complete two rounds of questions concerning the assessed risk for BE and decision for endoscopy referral of 6 patient cases (clinical vignettes). After the first round has been completed, an EsoCheck/EsoGuard educational information package and the second round of 6 clinical vignettes including EsoGuard results will be sent.
Key facts
- Study ID
- NCT05778851
- Run by
- Lucid Diagnostics, Inc.
- People needed
- 97
- Starts
- 2023-04-12
- Expected to finish
- 2024-08-19
- Last updated by the study team
- 2025-10-30
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Board-certified physicians whose scope of practice includes preventative care and disease screening, and/or those whose scope of practice include diagnosis and management of esophageal disease (examples include but are not limited to primary care physicians/ general practitioners, family medicine physicians, gastroenterologists, and foregut surgeons);
- Have between 1 to 40 years of post-residency clinical experience within their field of practice;
- Have an active panel (whether as part of a group practice, or individually) of over 1000 patients with an adult patient load of more than 50%.
You may not qualify if…
- None
Where it is running
- Lucid Diagnostics — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.